LEXXW (Lexaria Bioscience) PB Ratio: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LEXXW Lexaria Bioscience Corp LEXXW
36 GF Score
Price $0.00
! 4 Warning Signs
View Full Analysis

What is Lexaria Bioscience PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-09), Lexaria Bioscience's share price is $0.0012. Lexaria Bioscience's Book Value per Share for the quarter that ended in May. 2026 was $0.00. Hence, Lexaria Bioscience's PB Ratio of today is .

The historical rank and industry rank for Lexaria Bioscience's PB Ratio or its related term are showing as below:

LEXXW' s PB Ratio Range Over the Past 10 Years
Min: 0.9   Med: 5.95   Max: 64.9
Current: 3.27

During the past 13 years, Lexaria Bioscience's highest PB Ratio was 64.90. The lowest was 0.90. And the median was 5.95.

LEXXW's PB Ratio is ranked worse than
54.57% of 1215 companies
in the Biotechnology industry
Industry Median: 2.99 vs LEXXW: 3.27

During the past 12 months, Lexaria Bioscience's average Book Value Per Share Growth Rate was -32.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -51.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -33.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -3.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Lexaria Bioscience was 80.00% per year. The lowest was -66.20% per year. And the median was -14.10% per year.

Back to Basics: PB Ratio


Lexaria Bioscience  (NAS:LEXXW) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Lexaria Bioscience PB Ratio Related Terms


Lexaria Bioscience PB Ratio Historical Data

* Premium members only.

The historical data trend for Lexaria Bioscience's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexaria Bioscience PB Ratio Chart

Lexaria Bioscience Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Lexaria Bioscience Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LEXXW vs TPST, LPCN, CYCN: PB Ratio Comparison

For the Biotechnology subindustry, Lexaria Bioscience's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexaria Bioscience PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lexaria Bioscience's PB Ratio distribution charts can be found below:

* The bar in red indicates where Lexaria Bioscience's PB Ratio falls into.


LEXXW
36GF Score
Lexaria Bioscience Corp LEXXW
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lexaria Bioscience PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Lexaria Bioscience's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: May. 2026)
=0.0012/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Lexaria Bioscience Business Description

Other Exchanges LEXX:USA
Address 740 McCurdy Road, No. 100, Kelowna, BC, CAN, V1X 2P7
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
36GF Score

Get the complete analysis for LEXXW

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price